1. Cell Cycle/DNA Damage Epigenetics Membrane Transporter/Ion Channel
  2. HDAC P-glycoprotein
  3. 2-Propylpent-4-ynoic acid

2-Propylpent-4-ynoic acid (4-yn-VPA) is a HDAC inhibitor (with an IC50 of 0.5 mM against human HDAC). 2-Propylpent-4-ynoic acid also induces P-glycoprotein function, and exhibits teratogenicity, fetal growth inhibition and neurotoxicity. 2-Propylpent-4-ynoic acid shows significant stereospecific teratogenic effects, with the S-enantiomer being more teratogenic than the R-enantiomer and other analogs. The neurotoxicity of 2-Propylpent-4-ynoic acid is independent of its stereochemical structure. 2-Propylpent-4-ynoic acid has been used in studies related to the pathogenesis of colon cancer and neural tube defects such as exencephaly.

For research use only. We do not sell to patients.

2-Propylpent-4-ynoic acid

2-Propylpent-4-ynoic acid Chemical Structure

CAS No. : 24102-11-2

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

2-Propylpent-4-ynoic acid (4-yn-VPA) is a HDAC inhibitor (with an IC50 of 0.5 mM against human HDAC). 2-Propylpent-4-ynoic acid also induces P-glycoprotein function, and exhibits teratogenicity, fetal growth inhibition and neurotoxicity. 2-Propylpent-4-ynoic acid shows significant stereospecific teratogenic effects, with the S-enantiomer being more teratogenic than the R-enantiomer and other analogs. The neurotoxicity of 2-Propylpent-4-ynoic acid is independent of its stereochemical structure. 2-Propylpent-4-ynoic acid has been used in studies related to the pathogenesis of colon cancer and neural tube defects such as exencephaly[1][2].

In Vitro

2-Propylpent-4-ynoic acid (4-yn-VPA) (1 mM; 5 days) induces P-gp function in human colon adenocarcinoma SW620 cells, with an associated HDAC inhibition IC50 of 0.5 mM from HeLa nuclear extracts[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: human colon adenocarcinoma SW620 cells
Concentration: 1 mM
Incubation Time: 5 days
Result: Induced P-gp function with IC50 of 0.5 mM.
In Vivo

When 2-Propylpent-4-ynoic acid (4-yn-VPA) induces exencephaly in mice, the S-(-) isomer (0.40-1.05 mmol/kg; i.p.; gestational day 8; single administration) is 7.5 times more potent than the R (+) isomer (3-6 mmol/kg; i.p.; gestational day 8; single administration), with ED50 values of 0.83 mmol/kg and 6.19 mmol/kg, respectively[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Han:NMRI (female, 29-36 g, neural tube defect induced by treatment on gestational day 8)[2]
Dosage: 0.40, 0.60, 0.73, 0.86, 1.05 mmol/kg (S(-)-4-yn-VPA);
3.00, 4.50, 6.00 mmol/kg (R(+)-4-yn-VPA)
Administration: i.p.; single dose on gestational day 8
Result: Induced exencephaly at rates of 3%, 23%, 38%, 51%, 65% for S(-)-4-yn-VPA at 0.40, 0.60, 0.73, 0.86, 1.05 mmol/kg, respectively.
Caused embryolethality at rates of 10%, 8%, 17%, 38%, 51% for S(-)-4-yn-VPA at 0.40, 0.60, 0.73, 0.86, 1.05 mmol/kg, respectively.
Reduced fetal weights significantly (vs control) to 1.05 g and 1.04 g for S(-)-4-yn-VPA at 0.86 mmol/kg and 1.05 mmol/kg, respectively.
Induced exencephaly at rates of 1%, 26%, 38% for R(+)-4-yn-VPA at 3.00, 4.50, 6.00 mmol/kg, respectively.
Caused embryolethality at rates of 10%, 16%, 45% for R(+)-4-yn-VPA at 3.00, 4.50, 6.00 mmol/kg, respectively.
Reduced fetal weight significantly (vs control) to 1.00 g ± 0.10 for R(+)-4-yn-VPA at 6.00 mmol/kg.
Achieved an ED50 of 0.83 mmol/kg for exencephaly induction with S(-)-4-yn-VPA, and 6.19 mmol/kg for R(+)-4-yn-VPA.
Molecular Weight

140.18

Formula

C8H12O2

CAS No.
SMILES

O=C(O)C(CC#C)CCC

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
2-Propylpent-4-ynoic acid
Cat. No.:
HY-W787758
Quantity:
MCE Japan Authorized Agent: